304 related articles for article (PubMed ID: 32074287)
1. Latent Classes of Adherence to Oral Anticoagulation Therapy Among Patients With a New Diagnosis of Atrial Fibrillation.
Chen N; Brooks MM; Hernandez I
JAMA Netw Open; 2020 Feb; 3(2):e1921357. PubMed ID: 32074287
[TBL] [Abstract][Full Text] [Related]
2. Association of Direct Oral Anticoagulation Management Strategies With Clinical Outcomes for Adults With Atrial Fibrillation.
Derington CG; Goodrich GK; Xu S; Clark NP; Reynolds K; An J; Witt DM; Smith DH; O'Keeffe-Rosetti M; Lang DT; Ho PM; Cheetham TC; Comer AC; King JB
JAMA Netw Open; 2023 Jul; 6(7):e2321971. PubMed ID: 37410461
[TBL] [Abstract][Full Text] [Related]
3. Group based trajectory modeling to assess adherence to oral anticoagulants among atrial fibrillation patients with comorbidities: a retrospective study.
Mohan A; Majd Z; Trinh T; Paranjpe R; Abughosh SM
Int J Clin Pharm; 2022 Aug; 44(4):966-974. PubMed ID: 35776377
[TBL] [Abstract][Full Text] [Related]
4. Race/Ethnicity and Sex-Related Differences in Direct Oral Anticoagulant Initiation in Newly Diagnosed Atrial Fibrillation: A Retrospective Study of Medicare Data.
Essien UR; Magnani JW; Chen N; Gellad WF; Fine MJ; Hernandez I
J Natl Med Assoc; 2020 Feb; 112(1):103-108. PubMed ID: 32035755
[TBL] [Abstract][Full Text] [Related]
5. Adherence to Anticoagulation and Risk of Stroke Among Medicare Beneficiaries Newly Diagnosed with Atrial Fibrillation.
Hernandez I; He M; Brooks MM; Saba S; Gellad WF
Am J Cardiovasc Drugs; 2020 Apr; 20(2):199-207. PubMed ID: 31523759
[TBL] [Abstract][Full Text] [Related]
6. Trajectories of Oral Anticoagulation Adherence Among Medicare Beneficiaries Newly Diagnosed With Atrial Fibrillation.
Hernandez I; He M; Chen N; Brooks MM; Saba S; Gellad WF
J Am Heart Assoc; 2019 Jun; 8(12):e011427. PubMed ID: 31189392
[TBL] [Abstract][Full Text] [Related]
7. Prescription Patterns and Outcomes of Patients With Atrial Fibrillation Treated With Direct Oral Anticoagulants and Warfarin: A Real-World Analysis.
Kattoor AJ; Pothineni NV; Goel A; Syed M; Syed S; Paydak H; Mehta JL
J Cardiovasc Pharmacol Ther; 2019 Sep; 24(5):428-434. PubMed ID: 31035795
[TBL] [Abstract][Full Text] [Related]
8. Association of Anticoagulant Therapy With Risk of Fracture Among Patients With Atrial Fibrillation.
Lutsey PL; Norby FL; Ensrud KE; MacLehose RF; Diem SJ; Chen LY; Alonso A
JAMA Intern Med; 2020 Feb; 180(2):245-253. PubMed ID: 31764956
[TBL] [Abstract][Full Text] [Related]
9. Outcomes in a Warfarin-Treated Population With Atrial Fibrillation.
Björck F; Renlund H; Lip GY; Wester P; Svensson PJ; Själander A
JAMA Cardiol; 2016 May; 1(2):172-80. PubMed ID: 27437888
[TBL] [Abstract][Full Text] [Related]
10. Predictors of adherence to direct oral anticoagulants after cardiovascular or bleeding events in Medicare Advantage Plan enrollees with atrial fibrillation.
Fatima B; Mohan A; Altaie I; Abughosh S
J Manag Care Spec Pharm; 2024 May; 30(5):408-419. PubMed ID: 38701026
[TBL] [Abstract][Full Text] [Related]
11. Effect of Adherence to Oral Anticoagulants on Risk of Stroke and Major Bleeding Among Patients With Atrial Fibrillation.
Yao X; Abraham NS; Alexander GC; Crown W; Montori VM; Sangaralingham LR; Gersh BJ; Shah ND; Noseworthy PA
J Am Heart Assoc; 2016 Feb; 5(2):. PubMed ID: 26908412
[TBL] [Abstract][Full Text] [Related]
12. Switching warfarin to direct oral anticoagulants in atrial fibrillation: Insights from the NCDR PINNACLE registry.
Sciria CT; Maddox TM; Marzec L; Rodwin B; Virani SS; Annapureddy A; Freeman JV; O'Hare A; Liu Y; Song Y; Doros G; Zheng Y; Lee JJ; Daggubati R; Vadlamani L; Cannon C; Desai NR
Clin Cardiol; 2020 Jul; 43(7):743-751. PubMed ID: 32378265
[TBL] [Abstract][Full Text] [Related]
13. Association of Race and Ethnicity With Oral Anticoagulation and Associated Outcomes in Patients With Atrial Fibrillation: Findings From the Get With The Guidelines-Atrial Fibrillation Registry.
Essien UR; Chiswell K; Kaltenbach LA; Wang TY; Fonarow GC; Thomas KL; Turakhia MP; Benjamin EJ; Rodriguez F; Fang MC; Magnani JW; Yancy CW; Piccini JP
JAMA Cardiol; 2022 Dec; 7(12):1207-1217. PubMed ID: 36287545
[TBL] [Abstract][Full Text] [Related]
14. The HAS-BLED score has better prediction accuracy for major bleeding than CHADS2 or CHA2DS2-VASc scores in anticoagulated patients with atrial fibrillation.
Roldán V; Marín F; Manzano-Fernández S; Gallego P; Vílchez JA; Valdés M; Vicente V; Lip GY
J Am Coll Cardiol; 2013 Dec; 62(23):2199-204. PubMed ID: 24055744
[TBL] [Abstract][Full Text] [Related]
15. Atrial fibrillation bleeding risk and prediction while treated with direct oral anticoagulants in warfarin-naïve or warfarin-experienced patients.
Perino AC; Fan J; Pundi K; Schmitt S; Kothari M; Din N; Heidenreich PA; Turakhia MP
Clin Cardiol; 2022 Sep; 45(9):960-969. PubMed ID: 35946047
[TBL] [Abstract][Full Text] [Related]
16. Direct Oral Anticoagulant Adherence of Patients With Atrial Fibrillation Transitioned from Warfarin.
Pundi KN; Perino AC; Fan J; Schmitt S; Kothari M; Szummer K; Askari M; Heidenreich PA; Turakhia MP
J Am Heart Assoc; 2021 Dec; 10(23):e020904. PubMed ID: 34779243
[TBL] [Abstract][Full Text] [Related]
17. The Tasmanian atrial fibrillation study: Transition to direct oral anticoagulants 2011-2015.
Alamneh EA; Chalmers L; Bereznicki LR
Cardiovasc Ther; 2017 Jun; 35(3):. PubMed ID: 28177198
[TBL] [Abstract][Full Text] [Related]
18. The costs of warfarin underuse and nonadherence in patients with atrial fibrillation: a commercial insurer perspective.
Casciano JP; Dotiwala ZJ; Martin BC; Kwong WJ
J Manag Care Pharm; 2013 May; 19(4):302-16. PubMed ID: 23627576
[TBL] [Abstract][Full Text] [Related]
19. Association of Ischemic Stroke, Major Bleeding, and Other Adverse Events With Warfarin Use vs Non-vitamin K Antagonist Oral Anticoagulant Use in Patients With Atrial Fibrillation With a History of Intracranial Hemorrhage.
Tsai CT; Liao JN; Chiang CE; Lin YJ; Chang SL; Lo LW; Hu YF; Tuan TC; Chung FP; Chao TF; Lip GYH; Chen SA
JAMA Netw Open; 2020 Jun; 3(6):e206424. PubMed ID: 32478848
[TBL] [Abstract][Full Text] [Related]
20. Self-reported adherence to direct oral anticoagulants versus warfarin therapy in a specialized thrombosis service-a cross-sectional study of patients in a Canadian Health Region.
Bonsu KO; Young SW; Lee T; Nguyen HV; Chitsike RS
Eur J Clin Pharmacol; 2023 Jan; 79(1):117-125. PubMed ID: 36399203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
